Phase 2 trial reveals potential of DPP-1 inhibitor for bronchiectasis
The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...
Kalaburagi hospital adopts 250 TB patients for 6-month recovery programme
Kalaburagi: Dr Farooq Ahmad Manoor of Manur Hospital, Kalaburagi, has taken responsibility for 250 tuberculosis patients by ...
Analytics India Magazine16h
India Integrates AI into TB Diagnosis to Push Early Detection & Treatment
India’s intensified TB elimination strategy is deploying AI-powered handheld X-ray machines. These devices, combined with ...
Vizianagaram district tops in sputum tests for TB diagnosis in country
Visakhapatnam: Vizianagaram was one of 347 districts selected for a 100-day nationwide tuberculosis (TB) elimination campaign.
News-Medical.Net2d
Owlstone Medical secures investment from Cystic Fibrosis Foundation
("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today ...
Nation on MSN4d
Hospitals grapple with backlog of untested TB samples
Public health workers in 10 counties have reported a massive backlog of untested sputum samples, leaving hundreds of suspected tuberculosis (TB) patients stranded without diagnosis and treatment.For ...
360Dx6d
Cystic Fibrosis Foundation Invests $2.3M in Owlstone Medical
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Cystic Fibrosis Foundation6d
CF Foundation Invests Up to $2.3 Million to Develop Test for Lung Infections
The Foundation’s funding will support Owlstone Medical’s development of a breath test to help doctors diagnose and monitor ...